A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants

NCT05877053 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: CK-4021586
DRUG: Placebo for CK-4021586

Sponsor

Cytokinetics